Leadership Team
The Leadership Team at ARTHEx Biotech drives the strategic direction and vision of the company, focusing on the development and commercialization of AntagomiR oligonucleotides for treating Myotonic Dystrophy. Comprised of the Co-founders, CMO, and Executive Chairman & CEO, this team leverages their expertise in biotechnology and medicine to advance research, secure funding, and navigate regulatory pathways, ensuring the successful delivery of innovative therapies to patients.